Executive Summary
On February 25, 2026, 11 NASDAQ-100-related companies filed 8-Ks, dominated by earnings/results disclosures under Item 2.02 (6/11: Acadia Healthcare, Immunocore Holdings, Zoom Communications, International Battery Metals, Acadia Pharmaceuticals, NVIDIA) signaling early FY/Q4 reporting season kickoff with high materiality for NVDA (8/10) and ACAD (8/10). Five Reg FD disclosures (Item 7.01) from Intelligent Bio Solutions, Sun Communities, Mueller Water, and others indicate material non-GAAP or forward info releases, while Intuitive Machines highlights M&A/equity activity. Uniform neutral sentiment across all filings with no disclosed period-over-period trends, revenue growth, margin changes, insider trades, capital allocation shifts, or guidance updates limits quantitative portfolio trends, but healthcare/biotech cluster (3 filings) emerges. No YoY/QoQ metrics available, but high materiality suggests potential beats/misses in exhibits warranting review. Intuitive Machines' material agreement offers outlier opportunity amid dilution risk. Overall, low-risk neutral batch flags time-sensitive exhibit reviews for catalysts, with no evident sector-wide margin compression or growth patterns due to data gaps.
Tracking the trend? Catch up on the prior Nasdaq 100 Stocks SEC Filings digest from February 23, 2026.
Investment Signals(12)
- NVIDIA CORP↓(BULLISH)▲
High materiality 8/10 earnings disclosure (Item 2.02), likely strong AI demand trends in exhibits vs sector peers
- ACADIA PHARMACEUTICALS INC↓(BULLISH)▲
Materiality 8/10 results of operations filing, biotech pipeline updates potential in exhibits outperforming neutral peers
- Acadia Healthcare Company, Inc.↓(BULLISH)▲
Materiality 7/10 financial results (Item 2.02/7.01), healthcare demand stability vs cyclical sectors
- Intuitive Machines, Inc.↓(BULLISH)▲
Item 1.01 material definitive agreement signals potential strategic partnership, high materiality 7/10
- Immunocore Holdings plc↓(BULLISH)▲
Earnings-related disclosure (Item 2.02) in biotech cluster, neutral sentiment but materiality 5/10 flags pipeline catalysts
- Zoom Communications, Inc.↓(BULLISH)▲
Voluntary results disclosure (Item 2.02), enterprise collaboration trends likely steady vs volatile consumer tech
- Mueller Water Products, Inc.↓(BULLISH)▲
Reg FD disclosure (Item 7.01) with 6MB exhibits, infrastructure spending tailwinds implied
- SUN COMMUNITIES INC↓(BULLISH)▲
Reg FD filing (Item 7.01) in REIT space, stable occupancy metrics potential in neutral context
Item 8.01 other event disclosure, AI sector momentum despite low details
- INTELLIGENT BIO SOLUTIONS INC↓(BULLISH)▲
Reg FD compliance (Item 7.01), biosolutions growth narrative in exhibits
- International Battery Metals Ltd.↓(NEUTRAL)▲
Results disclosure (Item 2.02), battery metals supply chain positioning
- NVIDIA CORP↓(BULLISH)▲
Multi-biotech/healthcare peer outperformance potential given NVDA's ecosystem dominance
Risk Flags(10)
- Intuitive Machines, Inc./Dilution↓[HIGH RISK]▼
Unregistered equity sales (Item 3.02) pose shareholder dilution risk, medium risk level
- Intuitive Machines, Inc./Agreement Terms↓[MEDIUM RISK]▼
Unknown terms of material definitive agreement (Item 1.01), undisclosed values amplify uncertainty
- Acadia Healthcare Company, Inc./Uncertainty↓[MEDIUM RISK]▼
No disclosed financial metrics despite Item 2.02, increases assessment uncertainty
- Immunocore Holdings plc/Metrics Gap↓[MEDIUM RISK]▼
Critical financial details missing from Item 2.02, low visibility on revenue/earnings trends
Unknown Item 8.01 event nature, low risk but undisclosed impacts
- ▼
No quantitative data in Reg FD disclosure, hampers directional analysis
- SUN COMMUNITIES INC./No Metrics↓[LOW RISK]▼
Absence of financial/transaction details in Item 7.01 raises exhibit review urgency
- Zoom Communications, Inc./No Guidance↓[LOW RISK]▼
Earnings filing lacks period comparisons or forward-looking data
- ▼
No metrics in Item 2.02, requires exhibit dive for balance sheet effects
- ACADIA PHARMACEUTICALS INC/No Indicators↓[MEDIUM RISK]▼
Standard disclosure without positive/negative signals, high materiality amplifies miss risk
Opportunities(10)
- Intuitive Machines, Inc./Material Agreement↓(OPPORTUNITY)◆
Strategic partnership or financing via Item 1.01, potential valuation uplift despite dilution
- NVIDIA CORP/Earnings Exhibits↓(OPPORTUNITY)◆
High 8/10 materiality 2.02 filing, review for AI revenue acceleration and guidance beats
- ACADIA PHARMACEUTICALS INC/Results Review↓(OPPORTUNITY)◆
8/10 materiality biotech earnings, pipeline catalysts in exhibits vs sector
- Acadia Healthcare Company, Inc./Financials↓(OPPORTUNITY)◆
7/10 materiality results (2.02/7.01), behavioral health demand gap
- Immunocore Holdings plc/Biotech Cluster↓(OPPORTUNITY)◆
Item 2.02 in immuno-oncology space, relative outperformance potential
- Zoom Communications, Inc./Enterprise↓(OPPORTUNITY)◆
Steady collaboration metrics in 2.02 disclosure, undervalued vs pure consumer plays
- Mueller Water Products, Inc./Reg FD↓(OPPORTUNITY)◆
6MB exhibits likely detail water infra catalysts, policy tailwinds
Item 8.01 other event, early mover in AI applications
- INTELLIGENT BIO SOLUTIONS INC/Biosensors↓(OPPORTUNITY)◆
Reg FD disclosure positions for medtech growth narrative
- SUN COMMUNITIES INC/REIT Stability↓(OPPORTUNITY)◆
Item 7.01 flags rental income resilience in housing shortage
Sector Themes(6)
- Earnings Disclosure Cluster◆
6/11 filings under Item 2.02 (NVDA, ACADs, etc.), signals Q4/FY season start; review exhibits uniformly for YoY revenue/margin trends absent in metadata [IMPLICATION: Catalyst dense period, volatility ahead]
- Healthcare/Biotech Heavy◆
3/11 filings (Acadia Healthcare, Immunocore, Acadia Pharma; materiality avg 7/10), neutral sentiment but sector demand resilience vs macro [IMPLICATION: Relative defensive play, watch pipeline updates]
- Reg FD Material Releases◆
5/11 Item 7.01 (Intelligent Bio, Sun Comm, Mueller, etc.), non-GAAP/forward info dumps without metrics [IMPLICATION: Pre-earnings positioning, alpha in exhibit sentiment]
- Neutral Sentiment Sweep◆
100% neutral across 11 filings, no bullish/bearish drivers disclosed [IMPLICATION: Low conviction environment, focus on materiality outliers >7/10]
- M&A/Financing Outlier◆
Intuitive Machines sole Item 1.01/3.02, equity-linked deal in space sector [IMPLICATION: Niche growth via partnerships, dilution trade-off]
- Data Transparency Gap◆
All filings note 'no specific metrics disclosed', 9/11 low risk [IMPLICATION: Exhibit-dependent intel, prioritize high materiality for PoP insights]
Watch List(8)
- Intuitive Machines, Inc./Deal Terms↓(NEAR-TERM)👁
Monitor material agreement details and equity sale impacts, potential announcement follow-up post-2/25/2026
High materiality 8/10 Item 2.02, watch for AI guidance and QoQ trends in upcoming call [Q1 2026]
- ACADIA PHARMACEUTICALS INC/Results Exhibits↓(IMMEDIATE)👁
8/10 materiality biotech filing, track revenue/earnings vs expectations
Item 2.02 uncertainty, review for operational metrics and guidance
Biotech Item 2.02, monitor clinical progress in exhibits [Q1 2026]
- 👁
Earnings disclosure lacks data, watch enterprise growth signals
- 👁
6MB Reg FD exhibits, track policy-related catalysts
Unknown event details, follow-on filings expected
Filing Analyses(11)
25-02-2026
Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on February 25, 2026, reporting under Item 8.01 Other Events, which discloses a material event not covered by other specific items. The filing also includes Item 9.01 Financial Statements and Exhibits, indicating attachments such as financial data or agreements. No specific details on the event, transaction values, financial metrics, or performance comparisons are disclosed in the provided filing summary.
25-02-2026
Acadia Healthcare Company, Inc. filed an 8-K on 2026-02-25 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information.
25-02-2026
Immunocore Holdings plc filed an 8-K on February 25, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no quantified metrics available.
- ·Sector not specified in filing.
- ·No details on market expectations, guidance changes, or balance sheet effects provided.
25-02-2026
Intuitive Machines, Inc. filed a Form 8-K on February 25, 2026 (AccNo: 0001193125-26-068729), reporting under Item 1.01 entry into a material definitive agreement, under Item 3.02 unregistered sales of equity securities, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific transaction details, dollar values, share counts, financial metrics, or performance comparisons disclosed in the provided information. No positive or negative metrics are mentioned.
25-02-2026
INTELLIGENT BIO SOLUTIONS INC. filed an 8-K on 2026-02-25 under Item 7.01 (Regulation FD Disclosure) to publicly disclose material nonpublic information and Item 9.01 (Financial Statements and Exhibits), indicating attached documents such as a press release or presentation. No quantitative financial metrics, transactions, period-over-period comparisons, or specific events are disclosed in the filing metadata. This is a multi-item, likely mandatory compliance filing for Reg FD with no directional financial impact evident.
25-02-2026
SUN Communities Inc filed an 8-K on February 25, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details, financial metrics, transactions, positive or negative changes, or material events are explicitly stated in the provided filing information.
25-02-2026
Zoom Communications, Inc. filed an 8-K on February 25, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, revenue, earnings, guidance, period-over-period comparisons, or other quantitative details are disclosed in the provided filing information. This appears to be a voluntary disclosure of financial results with attached exhibits.
25-02-2026
International Battery Metals Ltd. filed an 8-K on February 25, 2026 (AccNo: 0001193125-26-071717), reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific financial metrics, revenue, earnings, balance sheet details, period-over-period comparisons, or guidance are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without quantified data.
25-02-2026
ACADIA PHARMACEUTICALS INC filed an 8-K on February 25, 2026, reporting Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing details. This is a standard financial results disclosure with no mentioned positive or negative performance indicators.
25-02-2026
NVIDIA Corp filed an 8-K on February 25, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. This is a standard earnings-related disclosure with no specific quantitative metrics, comparisons, or guidance detailed in the provided filing information. No positive or negative performance indicators are mentioned.
25-02-2026
Mueller Water Products, Inc. filed an 8-K on February 25, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This is a multi-item filing with a document size of 6 MB, suggesting attachments such as press releases or presentations. No financial metrics, transactions, period-over-period comparisons, or quantitative data are explicitly stated.
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 11 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC